Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hermanns

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
European Urology|April 23, 2015
Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year ExperiencePatrick O Richard, Michael A S Jewett, Jaimin R Bhatt, et al.
Cancer Biomarkers : Section a of Disease Markers|August 30, 2014
Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNAFoued Ghanjati, Agnes Beermann, Thomas Hermanns, et al.
The Journal of Urology|December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series DataChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
Neoplasia (New York, N.Y.)|January 20, 2019
Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell CarcinomaSvenja Bihr, Riuko Ohashi, Ariane L Moore, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2021
What's behind <sup>68</sup>Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patternsJan H Rüschoff, Daniela A Ferraro, Urs J Muehlematter, et al.
Journal of Endourology|January 8, 2019
Pure Bipolar Plasma Vaporization of the Prostate: Results from a Prospective 3D Ultrasound Volumetry Study with Clinical Outcome After 3 YearsThomas Hermanns, Oliver Gross, Christian D Fankhauser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2014
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysisArnoud J Templeton, Olga Ace, Mairéad G McNamara, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Oncotarget|April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific deathAshkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
Journal of Endourology|June 29, 2013
Pure bipolar plasma vaporization of the prostate: the Zürich experienceBenedikt Kranzbühler, Marian Severin Wettstein, Christian D Fankhauser, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
European Urology|April 23, 2015
Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year ExperiencePatrick O Richard, Michael A S Jewett, Jaimin R Bhatt, et al.
Cancer Biomarkers : Section a of Disease Markers|August 30, 2014
Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNAFoued Ghanjati, Agnes Beermann, Thomas Hermanns, et al.
The Journal of Urology|December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series DataChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
Neoplasia (New York, N.Y.)|January 20, 2019
Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell CarcinomaSvenja Bihr, Riuko Ohashi, Ariane L Moore, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2021
What's behind <sup>68</sup>Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patternsJan H Rüschoff, Daniela A Ferraro, Urs J Muehlematter, et al.
Journal of Endourology|January 8, 2019
Pure Bipolar Plasma Vaporization of the Prostate: Results from a Prospective 3D Ultrasound Volumetry Study with Clinical Outcome After 3 YearsThomas Hermanns, Oliver Gross, Christian D Fankhauser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2014
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysisArnoud J Templeton, Olga Ace, Mairéad G McNamara, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Oncotarget|April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific deathAshkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
Journal of Endourology|June 29, 2013
Pure bipolar plasma vaporization of the prostate: the Zürich experienceBenedikt Kranzbühler, Marian Severin Wettstein, Christian D Fankhauser, et al.
Pageof 19